Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04498-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Tzu-Lei Kuo und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan. Hauptthemen laut MEDLINE: Receptors, Interleukin-8B, Pancreatic Neoplasms, Neutrophils, Immunotherapy. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan.
- Division of Hematology & Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
- Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
- Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
- National Institute of Cancer Research, National Health Research Institutes, No. 367, Sheng-Li Road, Tainan, 704, Taiwan. hung1228@nhri.edu.tw.
- Department of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan. hung1228@nhri.edu.tw.
Förderung
- National Science and Technology Council
Zitieren
APA
Kuo, T. L., Hsiao, K. C., Liu, K. J., Chen, L. T., & Hung, W. C. (2026). Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04498-6
Vancouver
Kuo TL, Hsiao KC, Liu KJ, Chen LT, Hung WC. Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04498-6
BibTeX
@article{Kuo2026,
author = {Kuo, Tzu-Lei and Hsiao, Kuan-Chung and Liu, Ko-Jiunn and Chen, Li-Tzong and Hung, Wen-Chun},
title = {Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04498-6}
}
EUVIMED